Trade

with

Portola Pharmaceuticals Inc
(NASDAQ: PTLA)
AdChoices
26.48
-0.40
-1.49%
After Hours :
26.48
0.00
0.00%

Open

27.03

Previous Close

26.88

Volume (Avg)

181.45k (349.13k)

Day's Range

26.18-27.15

52Wk Range

19.59-31.48

Market Cap.

1.11B

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

41.40M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 10.53M

    • Net Income

    • -83.35M

    • Market Cap.

    • 1.11B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,099.99

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -5.97

    • Price/Sales

    • 108.70

    • Price/Book Value

    • 4.53

    • Price/Cash flow

    • -15.67

      • EBITDA

      • -81.99M

      • Return on Capital %

      • -39.19

      • Return on Equity %

      • -46.30

      • Return on Assets %

      • -39.19

      • Book Value/Share

      • 5.84

      • Shares Outstanding

      • 41.40M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 44.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -7.20

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -1,099.99

            • 39.38

            • Net Profit Margin

            • -1,099.99

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 6.60

              • 2.92

              • Quick Ratio

              • 6.46

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.22

              • 2.21

              • Book Value/Share

              • 5.84

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -10.01

                • 277.78

                • P/E Ratio 5-Year High

                • -11.72

                • 634.30

                • P/E Ratio 5-Year Low

                • -5.49

                • 124.82

                • Price/Sales Ratio

                • 109.89

                • 9.35

                • Price/Book Value

                • 4.60

                • 8.50

                • Price/Cash Flow Ratio

                • -15.67

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -46.30

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -39.19

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -46.30

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.04

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -84.18M
                  Operating Margin
                  -799.34
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -15.67
                  Ownership

                  Institutional Ownership

                  99.60%

                  Top 10 Institutions

                  61.38%

                  Mutual Fund Ownership

                  50.90%

                  Float

                  67.75%

                  5% / Insider Ownership

                  0.26%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® OTC Portfolio

                  •  

                    2,336,800

                  • 0.00

                  • 5.64

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    1,705,033

                  • 0.00

                  • 4.12

                  • Franklin Biotechnology Discovery

                  •  

                    1,005,401

                  • 165.21

                  • 2.44

                  • Eagle Small Cap Growth Fund

                  •  

                    862,217

                  • 0.00

                  • 2.08

                  • JPM Global Healthcare

                  •  

                    675,283

                  • 0.00

                  • 1.63

                  • Prudential Jennison Health Sciences

                  •  

                    634,971

                  • 0.00

                  • 1.53

                  • iShares Nasdaq Biotechnology

                  •  

                    616,331

                  • -1.85

                  • 1.58

                  • Franklin Biotechnology Discovery Fund

                  •  

                    585,900

                  • 14.95

                  • 1.42

                  • Pictet-Biotech

                  •  

                    573,005

                  • 0.07

                  • 1.50

                  • iShares Russell 2000 (AU)

                  •  

                    565,696

                  • -0.90

                  • 1.45

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    5,122,539

                  • -6.42%

                  • 12.37

                  • Fidelity Management and Research Company

                  •  

                    4,289,950

                  • +26.89%

                  • 10.36

                  • Temasek Holdings Ltd.

                  •  

                    4,233,568

                  • 0.00%

                  • 10.23

                  • Eastern Capital LTD

                  •  

                    1,876,784

                  • 0.00%

                  • 4.59

                  • Eagle Asset Management, Inc.

                  •  

                    1,729,458

                  • +6.85%

                  • 4.18

                  • Franklin Advisers, Inc.

                  •  

                    1,635,701

                  • +52.91%

                  • 3.95

                  • Sectoral Asset Management Inc

                  •  

                    1,365,152

                  • +12.61%

                  • 3.30

                  • Orbimed Advisors, LLC

                  •  

                    1,361,600

                  • +42.17%

                  • 3.29

                  • Vanguard Group, Inc.

                  •  

                    1,341,579

                  • +5.80%

                  • 3.24

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  -

                  Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.

                  Key People

                  Mr. William Lis

                  CEO/Director

                  Ms. Mardi C. Dier

                  CFO/Chief Accounting Officer/Executive VP

                  Mr. John T. Curnutte

                  Executive VP, Divisional

                  H. Ward Wolff

                  Director

                  John H. Johnson

                  Director

                  • Portola Pharmaceuticals Inc

                  • 270 East Grand Avenue

                  • South San Francisco, CA 94080

                  • USA.Map

                  • Phone: +1 650 246-7000

                  • Fax: +1 650 246-7376

                  • portola.com

                  Incorporated

                  2003

                  Employees

                  70

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: